Development

Articles

Cambrex is investing $24 Million in new, highly potent API manufacturing capacity at its Charles City, Iowa site.

Cambrex Adds HPAPI Capacity

Featuring software, parallel automated reactors, and other tools designed to facilitate design of experiments, development of the design space, and better process understanding and control, the Hyderabad facility came online on July 20

Neuland Laboratories Opens QbD-centered Process Engineering Lab

The addition of 20,000 sq. ft. of manufacturing and office space increases Avecia’s Milford, Ma, oligonucleotide capacity to 3.0 mol.


Nitto Denko Avecia Announces Manufacturing Expansion

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Cannabinoids have potential to treat a variety of diseases, but pharmaceutical companies must first develop cost-effective ways to access pharmaceutically pure materials without marijuana cultivation.

The Search for Efficient Synthesis of Complex Cannabinoids

A Supreme Court decision and improvements in analytical processes may speed the biosimilar approval process.


Biosimilars Overcome Legal and Analytical Hurdles

Tom Tice, PhD, is senior director, Global Technical Marketing, Evonik Industries.

Poly(lactide-glycolide) has been used for drug-delivery applications because of its beneficial physicochemical properties, long safety record, and reliable commercial supply.

A 30-Year History of PLG Applications in Parenteral Controlled Drug Release

Agnes Shanley is senior editor of Pharmaceutical Technology.

Industrial-scale continuous API manufacturing may offer cost and safety benefits.

Continuous API Manufacturing

Matthew Moorcroft is vice-president, global marketing for Cambrex.

As pharma models changed during the past 40 years, contract manufacturing capacity and services evolved to meet demand.

History Guides Future CMO Strategies

BASF plans to build a new world-scale ibuprofen production plant in Ludwigshafen and expand ibuprofen capacities at its Bishop, Texas plant. 

BASF Ups Ibuprofen Capacities in Germany and North America

SK Biotek plans to operate the Swords, Ireland API manufacturing facility as a contract development and manufacturing site.

Ingredients